Gordon C. Ibeanu

1.6k total citations
40 papers, 1.3k citations indexed

About

Gordon C. Ibeanu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Gordon C. Ibeanu has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Pharmacology. Recurrent topics in Gordon C. Ibeanu's work include Pharmacogenetics and Drug Metabolism (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and DNA Repair Mechanisms (4 papers). Gordon C. Ibeanu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and DNA Repair Mechanisms (4 papers). Gordon C. Ibeanu collaborates with scholars based in United States, Nigeria and France. Gordon C. Ibeanu's co-authors include Joyce A. Goldstein, Burhan I. Ghanayem, Christine Bouchardy, Simone Benhamou, Joyce Blaisdell, Pierre Dayer, Sankar Mitra, G. Wilkinson, Keizo Tano and Debabrata Chakravarti and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemistry.

In The Last Decade

Gordon C. Ibeanu

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon C. Ibeanu United States 17 572 523 322 123 96 40 1.3k
Qing-Yu Zhang United States 25 642 1.1× 671 1.3× 345 1.1× 77 0.6× 69 0.7× 47 1.6k
David B. Buckley United States 17 420 0.7× 499 1.0× 397 1.2× 122 1.0× 121 1.3× 21 1.2k
Philip Wastall United States 6 350 0.6× 525 1.0× 349 1.1× 101 0.8× 68 0.7× 8 1.2k
Russell Gotschall United States 21 533 0.9× 391 0.7× 178 0.6× 112 0.9× 133 1.4× 37 1.7k
Chunsong Yang United States 21 875 1.5× 381 0.7× 562 1.7× 70 0.6× 82 0.9× 38 1.6k
David J. Rance United Kingdom 15 636 1.1× 834 1.6× 452 1.4× 127 1.0× 65 0.7× 18 1.7k
Shangara S. Dehal United States 19 418 0.7× 584 1.1× 275 0.9× 149 1.2× 38 0.4× 27 1.5k
Punam Sandhu United States 16 410 0.7× 411 0.8× 292 0.9× 160 1.3× 108 1.1× 25 1.1k
Brian Ethell United Kingdom 16 376 0.7× 458 0.9× 299 0.9× 87 0.7× 69 0.7× 26 1.1k
Jasminder Sahi United States 21 379 0.7× 539 1.0× 479 1.5× 57 0.5× 52 0.5× 44 1.3k

Countries citing papers authored by Gordon C. Ibeanu

Since Specialization
Citations

This map shows the geographic impact of Gordon C. Ibeanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon C. Ibeanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon C. Ibeanu more than expected).

Fields of papers citing papers by Gordon C. Ibeanu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon C. Ibeanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon C. Ibeanu. The network helps show where Gordon C. Ibeanu may publish in the future.

Co-authorship network of co-authors of Gordon C. Ibeanu

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon C. Ibeanu. A scholar is included among the top collaborators of Gordon C. Ibeanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon C. Ibeanu. Gordon C. Ibeanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowaiye, Adekunle Babajide, et al.. (2025). Phyto-molecules show potentials to combat drug-resistance in bacterial cell membranes. Microbial Pathogenesis. 205. 107723–107723. 2 indexed citations
2.
Rowaiye, Adekunle Babajide, et al.. (2024). Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review. SHILAP Revista de lepidopterología. 2(1). 2 indexed citations
3.
Oli, Angus Nnamdi, et al.. (2024). Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature. Journal of Immunology Research. 2024(1). 8481761–8481761. 3 indexed citations
4.
Rowaiye, Adekunle Babajide, et al.. (2022). Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach. PLoS neglected tropical diseases. 16(3). e0009799–e0009799. 10 indexed citations
5.
Oli, Angus Nnamdi, et al.. (2021). Emergency medicine: magnesium sulphate injections and their pharmaceutical quality concerns. Heliyon. 7(5). e07099–e07099. 1 indexed citations
7.
Ibeanu, Gordon C.. (2018). Analysis of Gene Expression and Neuronal Phenotype in Neuroscreen-1 (NS-1) Cells. PubMed. 1(3). 1–13. 11 indexed citations
8.
Ma, Yanmei, Gordon C. Ibeanu, Liyao Wang, et al.. (2017). Selenium suppresses glutamate-induced cell death and prevents mitochondrial morphological dynamic alterations in hippocampal HT22 neuronal cells. BMC Neuroscience. 18(1). 15–15. 39 indexed citations
9.
Ma, Yanmei, Yongzhen Guo, Gordon C. Ibeanu, et al.. (2017). Overexpression of selenoprotein H prevents mitochondrial dynamic imbalance induced by glutamate exposure. International Journal of Biological Sciences. 13(11). 1458–1469. 18 indexed citations
10.
Bang, John J., et al.. (2017). Effects of Carbon Nanotubes on a Neuronal Cell Model In Vitro. SHILAP Revista de lepidopterología. 1(3). 70–77.
11.
Ibeanu, Gordon C., et al.. (2015). The Chemical Molecule B355252 is Neuroprotective in an In Vitro Model of Parkinson’s Disease. Cellular and Molecular Neurobiology. 36(7). 1109–1122. 14 indexed citations
12.
Huh, Eun Young, et al.. (2013). A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model. BMC Neuroscience. 14(1). 93–93. 24 indexed citations
13.
Kimple, Adam J., Adam Yasgar, Mark Hughes, et al.. (2008). A High Throughput Fluorescence Polarization Assay for Inhibitors of the GoLoco Motif/G-alpha Interaction. Combinatorial Chemistry & High Throughput Screening. 11(5). 396–409. 27 indexed citations
14.
Ibeanu, Gordon C., Joyce Blaisdell, Ronald J. Ferguson, et al.. (1999). A Novel Transversion in the Intron 5 Donor Splice Junction of CYP2C19 and a Sequence Polymorphism in Exon 3 Contribute to the Poor Metabolizer Phenotype for the Anticonvulsant Drug S-Mephenytoin. Journal of Pharmacology and Experimental Therapeutics. 290(2). 635–640. 87 indexed citations
15.
Ibeanu, Gordon C., Joyce Blaisdell, Burhan I. Ghanayem, et al.. (1998). An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. Pharmacogenetics. 8(2). 129–136. 79 indexed citations
16.
Ibeanu, Gordon C., Joyce A. Goldstein, Urs Meyer, et al.. (1998). Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin. Journal of Pharmacology and Experimental Therapeutics. 286(3). 1490–1495. 104 indexed citations
17.
Ibeanu, Gordon C., Burhan I. Ghanayem, Patricia Linko, et al.. (1996). Identification of Residues 99, 220, and 221 of Human Cytochrome P450 2C19 as Key Determinants of Omeprazole Hydroxylase Activity. Journal of Biological Chemistry. 271(21). 12496–12501. 81 indexed citations
18.
Tatsuka, Masaaki, Gordon C. Ibeanu, Satya Narayan, et al.. (1995). Structural Organization of the Mouse DNA Repair Gene, N -Methylpurine-DNA Glycosylase. DNA and Cell Biology. 14(1). 37–45. 16 indexed citations
20.
Ibeanu, Gordon C., et al.. (1987). Molecular cloning of Clostridium difficile toxin A gene fragment in λ gtll. FEBS Letters. 213(2). 249–253. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026